Brief: Aker Biomarine Receives Approval For Lysovetatm As New Dietary Ingredient In The US
Aug 10 (Reuters) - Aker Biomarine ASA AKBM.OL :
* AKER BIOMARINE HAS RECEIVED APPROVAL FOR LYSOVETATM AS A
NEW
DIETARY INGREDIENT IN THE US
Source text for Eikon: ID:nObiB9Y8Fa
Further company coverage: AKBM.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million